Literature DB >> 20299294

Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

Mohamed H Ahmed1, Emmanuel O Abu, Christopher D Byrne.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.
Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20299294     DOI: 10.1016/j.pcd.2010.02.004

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  20 in total

Review 1.  Childhood obesity: a life-long health risk.

Authors:  Matthias Barton
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

Review 2.  Current and Future Burden of Chronic Nonmalignant Liver Disease.

Authors:  Prowpanga Udompap; Donghee Kim; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

Review 3.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  Nonalcoholic fatty liver disease: implications for cardiovascular risk.

Authors:  Amreen Dinani; Arun Sanyal
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

Review 5.  Obstructive sleep apnea syndrome and fatty liver: association or causal link?

Authors:  Mohamed-H Ahmed; Christopher-D Byrne
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

6.  Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.

Authors:  Arun J Sanyal; Scott L Friedman; Arthur J McCullough; Lara Dimick-Santos
Journal:  Hepatology       Date:  2015-03-19       Impact factor: 17.425

7.  Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis.

Authors:  Yang Liu; Daizhan Zhou; Fang Zhang; Yanyang Tu; Yulei Xia; Hui Wang; Ben Zhou; Yi Zhang; Jingxia Wu; Xiang Gao; Zhishui He; Qiwei Zhai
Journal:  J Lipid Res       Date:  2012-01-09       Impact factor: 5.922

8.  Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.

Authors:  Kendall B Islam; Danielle Brandman; Janet N Chu; Max L Goldman; Rena K Fox
Journal:  Dig Dis Sci       Date:  2022-09-30       Impact factor: 3.487

9.  GPs' experiences and perceptions of early detection of liver disease: a qualitative study in primary care.

Authors:  Holly C Standing; Helen Jarvis; James Orr; Catherine Exley; Mark Hudson; Eileen Kaner; Barbara Hanratty
Journal:  Br J Gen Pract       Date:  2018-09-24       Impact factor: 5.386

Review 10.  The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.

Authors:  Said O Muhidin; Ahmed A Magan; Khalid A Osman; Shareef Syed; Mohamed H Ahmed
Journal:  J Obes       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.